CNC · 10-Q · 2026Q1 · Full report
Divestiture of Magellan Assets
CENTENE CORP · 2026-04-28 · Importance 58 · Surprise 68
In December 2025 Centene signed a definitive agreement to divest the remaining Magellan Health businesses.,Other segment revenues decreased 8% in Q1 2026 versus Q1 2025 driven by Magellan Health, and the company recorded adjustments to previously reported gains related to Magellan Rx totaling $10 million.,The divestiture is explicitly referenced as a completed definitive agreement (December 2025) and is expected to materially affect Other segment composition and related revenue recognition going forward.
Key facts
- In December 2025 Centene signed a definitive agreement to divest the remaining Magellan Health businesses.
- Total revenues in the Other segment decreased 8% in Q1 2026 compared to Q1 2025 driven by Magellan Health.
- A reduction to previously reported gain on sale of Magellan Rx of $10 million was recorded as an adjustment in Q1 periods.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | committed | — | In December 2025 Centene signed a definitive agreement to divest the remaining Magellan Health businesses. |
| assets | negative | committed | — | In December 2025 Centene signed a definitive agreement to divest the remaining Magellan Health businesses. |